Practice Capabilities

Loeb & Loeb represents both Asian companies doing business or seeking to raise debt or equity capital in the United States as well as US and multinational companies seeking to invest in or expand their businesses in the People’s Republic of China. Whether the work is in-bound or out-bound, our clients turn to Loeb & Loeb for critical business transactions that will extend their global reach.

Our China practice has rapidly become one of the most respected in the legal industry, especially in the areas of corporate finance and mergers and acquisition transactions. More than 60 Chinese companies have relied on us to help them go public in the United States. We also represent a list of private equity funds and investment banks in connection with their transactions in China. In addition, we represent a number of Chinese enterprises, creative artists and entrepreneurs seeking to expand into the US entertainment industry, and US media and entertainment clients seeking to grow and secure their interests in China.

Loeb & Loeb's representative office in Beijing brings us even closer to our Chinese clients and allows us to more effectively and efficiently deliver the sophisticated transactional advice that the country’s rapidly evolving legal system demands. Our specialized attorneys on the ground in Beijing, and our global team of more than 30 legal professionals with a focus on China, offer a depth and breadth of experience that is among the most respected in the industry.

We offer our clients a broad range of legal services to meet their domestic and international business and fund-raising needs. These capabilities include:

Initial and follow-on public offerings registered with the Securities and Exchange Commission	General corporate and ongoing public company representation
Alternative public offerings (SPACs and reverse mergers)	Corporate governance
PIPEs and other private equity and debt financings	Due diligence and investigative services
Mergers and acquisitions	Intellectual property including patents
Complex commercial and cross-border transactions	Management compensation plans including stock option plans
Going-private transactions	Labor and employment issues
Joint ventures	Outsourcing
Venture capital financing	Franchising
Entertainment financing, including co-production, co-financing, and restructuring transactions	Cross-border tax structuring

Service Approach

Our representative office in Beijing, in conjunction with our coast-to-coast practice in the United States, allows us to bridge cultural, time zone and language barriers to offer seamless access and service to our Chinese and Asian clients. For our US and multinational clients, this global presence enables us to provide a window to the many opportunities that lie ahead in China for foreign investment and trade as the country moves from a manufacturing to a technology-driven economy.

Cross-practice strengths that add value are especially critical for clients as they pursue business interests in China and throughout Asia. To harness our full service capabilities, we position counsel from our Advanced Media and Technology, Intellectual Property, Entertainment, Tax, Litigation, Patent, Employment and other practice specialty areas alongside our lead legal teams. Through this collaboration, we strive to deliver the most effective and efficient legal services possible. 

Clients and Industries

Our clients are public and private companies representing a broad range of industries whose legal requirements are as diverse as the countries in which they do business and the global consumers they serve. We also represent financial intermediaries in the capital-raising process, such as underwriters, placement agents and financial advisors, whose issuer clients are active in the People's Republic of China. From high technology to high fashion, transportation to toys, our attorneys have the legal experience it takes to open doors for opportunities that await in China, Asia, the United States and around the world.

Our clients include:

American Oriental Bioengineering (AOB)	Fuwei Films
Asia Entertainment & Resources Ltd.	Gulf Resources, Inc.
AutoChina International Limited (fka Spring Creek Acquisition Corp.)	Harbin Electric, Inc.
Brean Murray Carret & Co., LLC	IDG Films and IDG Asia
CBR Brewing Company	Jingwei International Limited
Chardan 2008 China Acquisition Corp.	Kyocera Corporation
Chardan Capital Markets, Inc.	Lihua International
Chardan North Acquisition Corp.	Maxim Group LLC
Chardan South Acquisition Corp.	Merriman Curhan Ford & Co.
China 3C Group	New Dragon Asia Limited
China Ceramics, Inc.	QKL Stores, Inc.
China Cord Blood Corporation (fka Pantheon China Acquisition Corp.)	Rodman & Renshaw LLC
China Energy Corporation	Roth Capital Partners, LLC
China Integrated Energy, Inc.	Sino Clean Energy, Inc.
China LianDi Clean Technology	Tiens Biotech Group, Inc.
China MediaExpress Holdings, Inc.	Vision Capital
China Networks, Inc.	WestPark Capital, Inc.
ChinaNet Online Media Group Limited	Xinhua News Agency
Cogo Group, Inc. (fka Comtech Group, Inc.)	Yanglin Soybean, Inc.
Funtalk China Holdings Limited	Yongye International Inc.
Fushi Copperweld, Inc.

Leadership in Law

In 2002, Loeb & Loeb attorneys helped Chinese developer and manufacturer of pharmaceutical and healthcare products, American Oriental Bioengineering, Inc. (AOBO) achieve a public flotation of its stock through a reverse merger. AOBO later became the first Chinese-based issuer to list on the New York Stock Exchange, where it made its debut in December 2006.

Our achievements and rankings attest to our leadership role. For example, Thomson Reuters ranks Loeb & Loeb #1 among law firms in underwritten public offerings by companies headquartered in China, as measured by the total number of deals closed over the three-year period from 2009 through 2011. Loeb & Loeb ranks #2 as measured by total deal value during this period.